SWOG clinical trial number
SWOG-9507
A Single Arm Phase II Study to Determine the Safety and Efficacy of 4-HPR N-(4-Hydroxyphenyl) Retinamide for Treating Oral Intraepithelial Neoplasia.
Closed
Phase
Accrual
10%
Abbreviated Title
A Single Arm Phase II Study to Determine the Safety and Efficacy of 4-HPR N-(4-Hydroxyphenyl) Retinamide for Treating Oral Intraepithelial Neoplasia.
Activated
12/01/1997
Closed
03/01/2000